Results 171 to 180 of about 5,696 (212)
Some of the next articles are maybe not open access.
17-alpha-hydroprogesterone caproate and cervical changes
American Journal of Obstetrics and Gynecology, 2010ObjectiveThe purpose of this study was to evaluate whether 17-a-hydroxyprogesterone caproate (17P) treatment affect changes in cervical length.Study DesignWomen with singleton pregnancy, between 25 and 33 + 6 weeks of gestation, who were hospitalized for preterm labor were included.
openaire +2 more sources
The treatment of advanced endometrial cancer with hydroxyprogesterone caproate
Gynecologic Oncology, 1974In 314 women with progressing advanced adenocarcinoma of the uterine corpus (endometrial cancer) no longer responding to established anticancer measures, hydroxyprogesterone caproate (1.0 or more g/wk intramuscularly for 4 or more wk) induced in 37.0% an objective response (averaging 20 mo in duration) consisting of regression in 30.2% and arrest of ...
openaire +2 more sources
Compounded hydroxyprogesterone caproate
American Journal of Obstetrics and Gynecology, 2013John L, Chollet +2 more
openaire +2 more sources
Immune effects of 17α-hydroxyprogesterone caproate
American Journal of Obstetrics and Gynecology, 2022openaire +2 more sources